Valuation: Teva Pharmaceutical Industries Limited

Market Cap 43.51B 0 37.27B 34.87B 31.92B 59.91B 4,163B 60.7B 412B 161B 2,091B 163B 160B 6,917B P/E 2026 *
50.1x
P/E 2027 * 20.5x
Enterprise Value 55.39B 0 47.45B 44.39B 40.64B 76.27B 5,300B 77.27B 525B 205B 2,662B 208B 203B 8,806B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 3.01x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
1 day-0.72%
1 week+2.99%
Current month+1.38%
1 month+14.58%
3 months+9.76%
6 months+2.70%
Current year+9.22%
1 week 10,650
Extreme 10650
11,240
1 month 9,450
Extreme 9450
11,240
Current year 8,860
Extreme 8860
11,350
1 year 5,990
Extreme 5990
11,350
3 years 3,250
Extreme 3250
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
20,310
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%+2.99% - - 43.51B
+0.88%+6.38%+76.86%+128.23% 1,119B
+1.07%+3.80%+51.03%+61.48% 651B
+1.20%+6.21%+26.47%+76.45% 468B
+1.02%+5.77%+43.09%+47.70% 374B
+0.85%+4.07%+23.88%+41.58% 302B
+1.26%+6.81%+1.59%+14.67% 259B
+1.88%+5.81%+48.54%+68.52% 238B
+1.59%+2.09%-15.52%-52.29% 208B
+1.87%+5.61%+25.81%+92.42% 181B
Average +1.09%+4.97%+31.31%+53.20% 422.21B
Weighted average by Cap. +1.12%+5.09%+44.31%+72.55%

Financials

2026 *2027 *
Net sales 16.58B 0 14.2B 13.29B 12.17B 22.83B 1,587B 23.13B 157B 61.23B 797B 62.26B 60.91B 2,636B 17.3B 0 14.82B 13.87B 12.7B 23.83B 1,656B 24.14B 164B 63.9B 832B 64.98B 63.56B 2,751B
Net income 1.14B 0 977M 914M 837M 1.57B 109B 1.59B 10.8B 4.21B 54.81B 4.28B 4.19B 181B 2.34B 0 2B 1.87B 1.71B 3.22B 224B 3.26B 22.13B 8.63B 112B 8.77B 8.58B 372B
Net Debt 11.88B 0 10.17B 9.52B 8.71B 16.35B 1,136B 16.57B 112B 43.86B 571B 44.6B 43.63B 1,888B 8.61B 0 7.38B 6.9B 6.32B 11.86B 824B 12.01B 81.54B 31.8B 414B 32.33B 31.63B 1,369B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
21/08/26 ILA 11,020.00 -0.72% 285,212
20/08/26 ILA 11,100.00 -0.98% 625,182
19/08/26 ILA 11,210.00 +1.17% 937,718
18/08/26 ILA 11,080.00 +2.50% 750,535
17/08/26 ILA 10,810.00 +1.03% 620,299
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
37.34USD
Average target price
41.40USD
Spread / Average Target
+10.87%

Quarterly revenue - Rate of surprise